Population pharmacokinetics of paritaprevir, ombitasvir, dasabuvir, ritonavir and ribavirin in hepatitis C virus genotype 1 infection: analysis of six phase III trials
暂无分享,去创建一个
S. Dutta | T. Podsadecki | R. Menon | W. Awni | Shringi Sharma | D. Eckert | S. Mensing | Akshanth R. Polepally | A. Khatri | Amit Khatri